Combinatorial Library Design of Mutation- Resistant Hiv Protease Inhibitors

نویسندگان

  • Sripriya Chellappan
  • Michael K. Gilson
چکیده

Title of Dissertation: COMBINATORIAL LIBRARY DESIGN OF MUTATIONRESISTANT HIV PROTEASE INHIBITORS. Sripriya Chellappan, Doctor of Philosophy, 2006 Dissertation directed by: Professor Michael K. Gilson Department of Molecular and Cellular Biology The emergence of HIV strains that are resistant to current HIV protease inhibitors in the past few years has become a major concern in AIDS treatment. The goal of this project is to design a combinatorial library of potential lead compounds that can bind to both the wild-type and mutant proteases and that can resist further mutations. A recent crystallographic study of complexes of HIV protease with its substrates has provided structural insights into the differential recognition of the substrates and inhibitors. It has been proposed that clinical resistance is a consequence of inhibitors failure to stay within the consensus substrate volume. In this work, we devised a quantitative indicator of the degree to which a candidate ligand falls outside the consensus substrate volume, and determined its correlation with the inhibitor’s sensitivity to clinically relevant resistant mutations. The validation of this hypothesis has encouraged us to use this strategy in our design of a combinatorial library of inhibitors. The compounds in a typical combinatorial library are built around a common structural scaffold possessing multiple connection points where substituents can be added by reliable synthetic steps. As the number of compounds encompassed by such a combinatorial scheme frequently exceeds what can actually be synthesized and tested, virtual screening methods are sought to shortlist the compounds. Even though these methods require only seconds to minutes of CPU time per compound, exhaustive screening of an entire virtual combinatorial library is computationally demanding. We therefore implemented a simple algorithm of combining substituents that have been optimized independently for the substituent sites. This method was compared with Genetic Algorithm, a global optimization method and was found equally efficient. This simple method was hence chosen for the design process. A combinatorial library based on these ideas and methods has been synthesized and tested. It includes four compounds with nanomolar inhibition constants. Two of them were shown to have retained affinity against a panel of treatment-resistant mutations. COMBINATORIAL LIBRARY DESIGN OF MUTATIONRESISTANT HIV PROTEASE INHIBITORS

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Resistance mechanism of human immunodeficiency virus type-1 protease to inhibitors: A molecular dynamic approach

Human immunodeficiency virus type 1 (HIV-1) protease inhibitors comprise an important class of drugs used in HIV treatments. However, mutations of protease genes accelerated by low fidelity of reverse transcriptase yield drug resistant mutants of reduced affinities for the inhibitors. This problem is considered to be a serious barrier against HIV treatment for the foreseeable future. In this st...

متن کامل

THE DESIGN, MODELING AND EVALUATION OF POTENTIAL HIV PROTEASE INHIBITORS USING BLITZ, AN INTERACTIVE COMPUTER GRAPHICS WORKING TOOL

Several nonpeptide small molecules were designed as potential inhibitors of HIV protease and their structures were constructed by computer-aided molecular modeling and docked iwo the active site of HIV protease. Models of the complexes of inhibitors and the HIV protease were refined using nonbonded and H-bonding terms. The refined energy of selected complexes showed that the designed inhib...

متن کامل

Using Hierarchical Virtual Screening To Combat Drug Resistance of the HIV-1 Protease

Human immunodeficiency virus (HIV) protease inhibitors (PIs) are important components of highly active anti-retroviral therapy (HAART) that block the catalytic site of HIV protease, thus preventing maturation of the HIV virion. However, with two decades of PI prescriptions in clinical practice, drug-resistant HIV mutants have now been found for all of the PI drugs. Therefore, the continuous dev...

متن کامل

Altered substrate specificity of drug-resistant human immunodeficiency virus type 1 protease.

Resistance to human immunodeficiency virus type 1 protease (HIV PR) inhibitors results primarily from the selection of multiple mutations in the protease region. Because many of these mutations are selected for the ability to decrease inhibitor binding in the active site, they also affect substrate binding and potentially substrate specificity. This work investigates the substrate specificity o...

متن کامل

Design of new potent HTLV-1 protease inhibitors: in silico study

HTLV-1 and HIV-1 are two major causes for severe T-cell leukemia disease and acquired immune deficiency syndrome (AIDS). HTLV-1 protease, a member of aspartic acid protease family, plays important roles in maturation during virus replication cycle. The impairment of these proteases results in uninfectious HTLV-1virions.Similar to HIV-1protease deliberate mutations that confer drug resistance on...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

عنوان ژورنال:

دوره   شماره 

صفحات  -

تاریخ انتشار 2007